CLINICAL_TRIALS
trial_result
· 2025-11-26
Clinical Trial Update: A Dose-response Study of Tranexamic Acid in Total Hip Arthroplasty [Phase 2]
Summary
The Phase 2 dose-response study of tranexamic acid in total hip arthroplasty has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Arthropathy of Hip | Phase 2 | Status: COMPLETED